Nov 1 (Reuters) - Bionomics Ltd (BNO) :
- BIONOMICS RECEIVES FDA CLEARANCE OF IND FOR EVALUATION OF BNC210 IN A PHASE 2 SOCIAL ANXIETY DISORDER PREVAIL STUDY
- BIONOMICS LTD - PREVAIL STUDY REMAINS ON TARGET TO INITIATE BY END OF 2021 AND IS EXPECTED TO READ OUT TOPLINE DATA BY END OF 2022
Nov 1 (Reuters) - Bionomics Ltd (BNO) : BIONOMICS RECEIVES FDA...
Add to My Watchlist
What is My Watchlist?